Find in Library

Posttransplant lymphoproliferative disorders (PTLDs) are life-threatening complications of solid-organ and bone marrow transplantations leading to a high mortality. PTLD represents a heterogeneous group of lymphoproliferative diseases. They become clinically relevant because of the expansion of transplantation medicine together with the development of potent immunosuppressive drugs associated now with a long survival. The risk of PTLD is highest in the early posttransplant period, but the cumulative risk increases with time. We report a case of two sequential malignancies – carcinoma bladder - 13 years and now gastric lymphoma - 15 years after renal transplantation in a 73-year-old male.